Inhibition of protein kinase C might be harmful to diabetic retinopathy

This publication has 9 references indexed in Scilit:

• Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy
  American Journal of Nephrology, 2004
• Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes
  Diabetologia, 2003
• Advanced Glycation End Products-Induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor in Bovine Retinal Pericytes
  Biochemical and Biophysical Research Communications, 2002
• Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy
  New England Journal of Medicine, 2000
• Protein kinase C activation and the development of diabetic complications.
  Diabetes, 1998
• Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
  Science, 1996
• Vascular Pericytes Not Only Regulate Growth, but Also Preserve Prostacyclin-Producing Ability and Protect Against Lipid Peroxide-Induced Injury of Cocultured Endothelial Cells
  Biochemical and Biophysical Research Communications, 1993
• Current Hypotheses for the Biochemical Basis of Diabetic Retinopathy
  Diabetes Care, 1992
• Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
  Proceedings of the National Academy of Sciences, 1991